Skip to content
10-Q

Quarterly Report

Unity Biotechnology, Inc.

0000950170-25-056789

← back to feed
Filed
Apr 22, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 18, 2025 17.21M sh
Shares Diluted Q1 2025 · Mar 31, 2025 16.87M sh
Shares Diluted Q1 2025 · Mar 31, 2024 16.79M sh
Operating Cash Flow Q1 2025 · Mar 31, 2025 −$6.36M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$5.18M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $8M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $7.58M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $7.43M
Stockholders Equity Q1 2025 · Mar 31, 2025 −$205K
Stockholders Equity Q1 2025 · Dec 31, 2024 $6.49M
Stockholders Equity Q1 2025 · Mar 31, 2024 $23.99M
Stockholders Equity Q1 2025 · Dec 31, 2023 $28.4M
Current Liabilities Q1 2025 · Mar 31, 2025 $9.07M
Current Liabilities Q1 2025 · Dec 31, 2024 $9.26M
Total Liabilities Q1 2025 · Mar 31, 2025 $30.55M
Total Liabilities Q1 2025 · Dec 31, 2024 $31.17M
Current Assets Q1 2025 · Mar 31, 2025 $17.65M
Current Assets Q1 2025 · Dec 31, 2024 $24.27M
Total Assets Q1 2025 · Mar 31, 2025 $30.35M
Total Assets Q1 2025 · Dec 31, 2024 $37.66M
Eps Diluted Q1 2025 · Mar 31, 2025 −$0.43
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.34
Eps Basic Q1 2025 · Mar 31, 2025 −$0.43
Eps Basic Q1 2025 · Mar 31, 2024 −$0.34
Sga Expense Q1 2025 · Mar 31, 2025 $4.12M
Sga Expense Q1 2025 · Mar 31, 2024 $3.88M
Rd Expense Q1 2025 · Mar 31, 2025 $2.77M
Rd Expense Q1 2025 · Mar 31, 2024 $3.72M
Net Income Q1 2025 · Mar 31, 2025 −$7.3M
Net Income Q1 2025 · Mar 31, 2024 −$5.79M
Operating Income Q1 2025 · Mar 31, 2025 −$6.89M
Operating Income Q1 2025 · Mar 31, 2024 −$7.6M